Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ohman

Showing results (111-120 of 186) with videos related to

Pageof 19
Sort By:
Chest|February 7, 2001
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safetyJ Hirsh, T E Warkentin, S G Shaughnessy, et al.
The American Journal of Cardiology|December 15, 1990
Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarctionP Clemmensen, E M Ohman, D C Sevilla, et al.
Coronary Artery Disease|July 1, 1994
Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupS G Ellis, A M Lincoff, B S George, et al.
Journal of the American College of Cardiology|January 1, 1996
Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR)P B Berger, D R Holmes, E M Ohman, et al.
The American Journal of Cardiology|June 1, 1993
Ratio of ST-segment and myoglobin slopes to estimate myocardial salvage during thrombolytic therapy for acute myocardial infarctionJ M Baskin, M L Wilkins, E M Ohman, et al.
Journal of Electrocardiology|March 27, 2001
Moving toward a new definition of acute myocardial infarction for the 21st century: status of the ESC/ACC consensus conference. European Society of Cardiology and American College of CardiologyG S Wagner, M C Bahit, D Criger, et al.
Journal of the American College of Cardiology|August 31, 2001
Does the presence of thrombus seen on a coronary angiogram affect the outcome after percutaneous coronary angioplasty? An Angiographic Trials Pool data experienceM Singh, G S Reeder, E M Ohman, et al.
Circulation|January 29, 2003
Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) TrialJ P Ottervanger, P Armstrong, E S Barnathan, et al.
The American Journal of Cardiology|October 8, 1999
Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteriesJ M Miller, R Smalling, E M Ohman, et al.
Coronary Artery Disease|November 21, 1998
Increased baseline levels of platelet P-selectin, and platelet-endothelial cell adhesion molecule-1 in patients with acute myocardial infarction as predictors of unsuccessful thrombolysisP A Gurbel, V L Serebruany, A R Shustov, et al.
Pageof 19

Showing results (111-120 of 186) with videos related to

Sort By:
Pageof 19
Chest|February 7, 2001
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safetyJ Hirsh, T E Warkentin, S G Shaughnessy, et al.
The American Journal of Cardiology|December 15, 1990
Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarctionP Clemmensen, E M Ohman, D C Sevilla, et al.
Coronary Artery Disease|July 1, 1994
Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupS G Ellis, A M Lincoff, B S George, et al.
Journal of the American College of Cardiology|January 1, 1996
Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR)P B Berger, D R Holmes, E M Ohman, et al.
The American Journal of Cardiology|June 1, 1993
Ratio of ST-segment and myoglobin slopes to estimate myocardial salvage during thrombolytic therapy for acute myocardial infarctionJ M Baskin, M L Wilkins, E M Ohman, et al.
Journal of Electrocardiology|March 27, 2001
Moving toward a new definition of acute myocardial infarction for the 21st century: status of the ESC/ACC consensus conference. European Society of Cardiology and American College of CardiologyG S Wagner, M C Bahit, D Criger, et al.
Journal of the American College of Cardiology|August 31, 2001
Does the presence of thrombus seen on a coronary angiogram affect the outcome after percutaneous coronary angioplasty? An Angiographic Trials Pool data experienceM Singh, G S Reeder, E M Ohman, et al.
Circulation|January 29, 2003
Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) TrialJ P Ottervanger, P Armstrong, E S Barnathan, et al.
The American Journal of Cardiology|October 8, 1999
Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteriesJ M Miller, R Smalling, E M Ohman, et al.
Coronary Artery Disease|November 21, 1998
Increased baseline levels of platelet P-selectin, and platelet-endothelial cell adhesion molecule-1 in patients with acute myocardial infarction as predictors of unsuccessful thrombolysisP A Gurbel, V L Serebruany, A R Shustov, et al.
Pageof 19